CLOs on the Move

Palisades Medical Center

www.palisadesmedical.org

 
Palisades Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Palisades Medical Center is based in North Bergen, NJ. You can find more information on Palisades Medical Center at www.palisadesmedical.org
  • Number of Employees: 1K-5K
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Chartered Health Plan/DC HealthCare Alliance

Chartered Health Plan/DC HealthCare Alliance is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Technology Locator Healthcare

Technology Locator Healthcare is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Center for Biomedical Continuing Education

Center for Biomedical Continuing Education is a Irving, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MD Logic

MD Logic is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.